LIVE

USPH

U.S. Physical Therapy, Inc.

USPH

NYSE·Healthcare·Medical - Care Facilities·Mkt cap $1.1B

$72.35

+1.46%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$58.19 - $93.50

P/E

144.70

Fwd P/E

25.86

Beta

1.16

Div Yield

2.55%

Avg Vol

210.7K

Shares Out

15.2M

Mkt Cap

$1.1B

Price action

Price chart

Down 11.6% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • Extensive geographic footprint with 591 clinics in 39 states providing scale and market penetration
  • Diversified revenue model combining direct patient care with corporate wellness and injury prevention contracts
  • Established relationships with Fortune 500 companies, insurers, and healthcare systems creating sticky recurring revenue
  • Specialized expertise in orthopedic, sports medicine, and neurological rehabilitation with certified athletic trainers

Bear Case

2 risks

  • Average volatility.
  • Premium valuation to Healthcare Facilities peers

Growth

Moderate growth ahead

Shift toward outpatient care and away from hospital-based rehabilitation services

Value

Premium valuation to Healthcare Facilities peers

Momentum

Stable

-3.3% over 3m

Quality

Stable

Strong fundamentals

Dividend

Solid

2.55% yield

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Apr 30, 2026

Q2 26 RECAP

MAY 6, 2026

Reported EPS of $0.46 vs $0.55 consensus (-16.4% surprise). Revenue of $198.3M vs $200.9M expected (-1.3%).

EPS miss
Revenue miss

EPS surprise · last 4Q

0 of 1 beats

Q2 26

-16.4%

Next: Apr 30, 2026

Revenue trend · last 8Q

+17%

-2%

-2%

-2%

+12%

+30%

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$167.2M

$168.0M

$180.4M

$152.5M

$164.2M

$164.0M

$202.7M

$198.3M

Margins · last 8Q

Gross

Operating

Profit

-2.2%

Wall Street consensus

3 analysts · 100% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

3

100%

Hold

0%

Sell

0%

Median Price Target

$90.00

+24.4% vs $72.35

Low $90.00
Median $90.00
High $90.00

Latest: Citi · Jun 24, 2026

1 analyst covering

vs Industry

How USPH stacks vs Medical - Care Facilities

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.